Recombinant TNFSF11 (Denosumab Biosimilar) antibody (PE)

Catalog No. ABIN7867461

The Human Monoclonal anti-TNFSF11 (Denosumab Biosimilar) antibody is suitable to detect TNFSF11 (Denosumab Biosimilar) in samples from Human. It has been validated for FACS.

Quick Overview for Recombinant TNFSF11 (Denosumab Biosimilar) antibody (PE) (ABIN7867461)

Target: TNFSF11 (Denosumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This TNFSF11 (Denosumab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Product Details anti-TNFSF11 (Denosumab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-TNFSF11 (denosumab biosimilar)mAb

Isotype: IgG2

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid PBS with 0.05 %  Proclin300, 1 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for TNFSF11 (Denosumab Biosimilar)

Target: TNFSF11 (Denosumab Biosimilar)

Alternative Name: denosumab biosimilar

Target Type: Biosimilar

Background:

Synonyms: CD254,hRANKL2,ODF,OPGL,OPTB2,RANKL,sOdf,TNLG6B,TRANCE,AMG162

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.